CARLSON MARILYN R. 4
4 · Evoke Pharma Inc · Filed Mar 3, 2020
Insider Transaction Report
Form 4
Evoke Pharma IncEVOK
CARLSON MARILYN R.
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-02-28+200,000→ 200,000 totalExercise: $1.23Exp: 2030-02-27→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]One-half of the stock options will vest in 48 equal monthly installments over the four-year period beginning on January 1, 2020, subject to the reporting person's continued service to the issuer through each such vesting date. The other half of the stock options will vest in 48 equal monthly installments over the four-year period beginning on the date, if any, on which the U.S. Food and Drug Administration approves the Issuer's new drug application for Gimoti, subject to the reporting person's continued service to the issuer through each such vesting date.